{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Rhinitis", "endoscopy", "herbal medicine", "inflammation", "nasal steroid", "quality of life", "sinusitis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33912859", "DateRevised": {"Year": "2022", "Month": "04", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.4274/tao.2020.6098"], "Journal": {"ISSN": "2667-7474", "JournalIssue": {"Volume": "59", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Mar"}}, "Title": "Turkish archives of otorhinolaryngology", "ISOAbbreviation": "Turk Arch Otorhinolaryngol"}, "ArticleTitle": "A Herbal Formula in the Therapy of Acute Postviral Rhinosinusitis.", "Pagination": {"StartPage": "33", "EndPage": "42", "MedlinePgn": "33-42"}, "Abstract": {"AbstractText": ["To assess the effects and adverse events of preparation Sinulan forte<sup>\u00ae</sup> containing extracts of five medicinal plants in comparison to mometasone furoate nasal spray (MFNS) in therapy of acute postviral rhinosinusitis (APRS).", "We included 46 APRS patients in this prospective investigation and randomized to two groups. The patients in group 1 (n=23) received MFNS 200 \u03bcg two times/day for ten days, and patients in group 2 (n=23) received Sinulan forte<sup>\u00ae</sup>, tablets 225 mg per os, two times/day also for ten days. We evaluated the total symptom score (TSS), the separate scores for individual symptoms (nasal congestion, rhinorrhea, postnasal discharge, facial pain, impaired sense of smell), the quality-of-life outcome, and the findings from nasal endoscopy (edema of the nasal mucosa, nasal secretion) prior and after the therapy.", "Significantly lower absolute post-treatment scores and better relative improvement were identified for TSS, nasal congestion, facial pain, loss of the sense of smell, edema of the mucosa and nasal secretion in patients receiving herbal preparation (group 2). However, lower absolute post-treatment score and better relative improvement were found for rhinorrhea and postnasal drip in group 1. Clinically important differences were found regarding the TSS and endoscopic findings, with no adverse effects in group 2, but in group 1 two patients had mild nasal bleeding and two had sensation of dryness in the nasal mucosa.", "Herbal product Sinulan forte<sup>\u00ae</sup> can be a safe and effective treatment for APRS. Our results suggest no adverse events of this herbal preparation in comparison to intranasal corticosteroid spray therapy."], "CopyrightInformation": "\u00a9Copyright 2021 by Official Journal of the Turkish Society of Otorhinolaryngology and Head and Neck Surgery."}, "AuthorList": [{"Identifier": ["0000-0002-8453-7272"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Otorhinolaryngology, Military Medical Academy Faculty of Medicine, University of Defence, Belgrade, Serbia."}], "LastName": "Peric", "ForeName": "Aleksandar", "Initials": "A"}, {"Identifier": ["0000-0002-5377-1525"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ear Nose and Throat Hospital \"Doctor Zutic\", Belgrade, Serbia."}], "LastName": "Gacesa", "ForeName": "Dejan", "Initials": "D"}, {"Identifier": ["0000-0002-0132-2277"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia."}], "LastName": "Barac", "ForeName": "Aleksandra", "Initials": "A"}, {"Identifier": ["0000-0002-4187-7584"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy, Military Medical Academy Faculty of Medicine, University of Defence, Belgrade, Serbia."}], "LastName": "Peric", "ForeName": "Aneta", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Turkey", "MedlineTA": "Turk Arch Otorhinolaryngol", "NlmUniqueID": "101682806", "ISSNLinking": "2667-7466"}, "CoiStatement": "Conflict of Interest: The authors have no conflict of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alobid I, Mullol J. Management of rhinosinusitis today. Clin Pulm Med. 2008;15:332\u201341."}, {"Citation": "Klossek JM, Mesbah K. Presentation and treatment of acute maxillary sinusitis in general practice: a French observational study. Rhinology. 2011;49:84\u20139.", "ArticleIdList": ["21468380"]}, {"Citation": "Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol. 2016;6:S22\u2013209.", "ArticleIdList": ["26889651"]}, {"Citation": "Park JJ, Bachert C, Dazert S, Kostev K, Seidel DU. Current healthcare pathways in the treatment of rhinosinusitis in Germany. Acta Otolaryngol. 2018;138:1086\u201391.", "ArticleIdList": ["30686105"]}, {"Citation": "Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1\u2013464.", "ArticleIdList": ["32077450"]}, {"Citation": "Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116:1289\u201395.", "ArticleIdList": ["16337461"]}, {"Citation": "E\u011filmez OK, K\u00f6kten N, Kalc\u0131o\u011flu MT, Do\u011fan Ekici AI, \u015eerifler S, Ye\u015filada E. Investigation of the protective effect of Nigella sativa oil in cisplatin induced oral mucositis:an experimental study. Turk Arch Otorhinolaryngol. 2020;58:10\u20135.", "ArticleIdList": ["PMC7162592", "32313889"]}, {"Citation": "Laccourreye O, Werner A, Laccourreye L, Bonfils P. Benefits, pitfalls and risks of phytotherapy in clinical practice in otorhinolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:95\u20139.", "ArticleIdList": ["27914909"]}, {"Citation": "Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections:a systematic review of safety and efficacy. Planta Med. 2004;70:293\u20138.", "ArticleIdList": ["15095142"]}, {"Citation": "Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine. 2002;9:589\u201397.", "ArticleIdList": ["12487322"]}, {"Citation": "Saxena RC, Singh R, Kumar P, Yadav SC, Negi MPS, Saxena VS, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold\u2122) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 2010;17:178\u201385.", "ArticleIdList": ["20092985"]}, {"Citation": "Hu XY, Wu RH, Logue M, Blondel C, Lai LYW, Stuart B, et al. Andrographis paniculata (Chu\u0101n X\u012bn Li\u00e1n) for symptomatic relief of acute respiratory tract infections in adults and children:a systematic review and meta-analysis. PLoS ONE. 2017;12:e0181780.", "ArticleIdList": ["PMC5544222", "28783743"]}, {"Citation": "Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012;50:1\u201312.", "ArticleIdList": ["22469599"]}, {"Citation": "Pfaar O, Mullol J, Anders C, H\u00f6rmann K, Klimek L. Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis:a randomized double-blind, placebo-controlled trial. Rhinology. 2012;50:37\u201344.", "ArticleIdList": ["22469604"]}, {"Citation": "Meltzer EO, Wallace D, Dykewitz M, Shneyer L. Minimal clinically important difference (MCID) in allergic rhinitis:Agency for Healthcare Research and Quality or anchor-based thresholds. J Allergy Clin Immunol Pract. 2016;4:682\u20138.e6.", "ArticleIdList": ["27084419"]}, {"Citation": "Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effect of andrographolide. Int Immunopharmacol. 2009;9:313\u20138.", "ArticleIdList": ["19110075"]}, {"Citation": "Kou W, Sun R, Wei P, Yao HB, Zhang C, Tang XY, Hong SL. Andrographolide suppresses IL-6/Stat3 signaling in peripheral blood mononuclear cells from patients with chronic rhinosinusitis with nasal polyps. Inflammation. 2014;37:1738\u201343.", "ArticleIdList": ["24803294"]}, {"Citation": "Riaz M, Zia-Ul-Haq M, Jaafar HZE. Common mullein, pharmacological and chemical aspects. Rev Bras Farmacogn. 2013;23:948\u201359."}, {"Citation": "Passali D, Cambi J, Passali FM, Bellussi LM. Phytoneering:a new way of therapy for rhinosinusitis. Acta Otorhinolaryngol Ital. 2015;35:1\u20138.", "ArticleIdList": ["PMC4443571", "26015644"]}, {"Citation": "Kreindler JL, Chen B, Kreitman Y, Kofonow J, Adams KM, Cohen NA. The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am J Rhinol Allergy. 2012;26:439\u201343.", "ArticleIdList": ["23232192"]}, {"Citation": "Meltzer EO, Teper A, Danzig M. Intranasal corticosteroids in the treatment of acute rhinosinusitis. Curr Allergy Asthma Rep. 2008;8:133\u20138.", "ArticleIdList": ["18417055"]}, {"Citation": "Keith PK, Dymek A, Pfaar O, Fokkens W, Kirby SY, Wu W, et al. Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis:a randomized placebo-controlled study. Prim Care Respir J. 2012;21:267\u201375.", "ArticleIdList": ["PMC6548020", "22614920"]}, {"Citation": "Meltzer EO, Gates D, Bachert C. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis. Ann Allergy Asthma Immunol. 2012;108:275\u20139.", "ArticleIdList": ["22469449"]}, {"Citation": "Sohu HG, Park SJ, Ryu IS, Lim HW, Song YJ, Yeo NK. Comparison of clinical presentation and surgical outcomes between recurrent acute rhinosinusitis and chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 2018;127:763\u20139.", "ArticleIdList": ["30095001"]}, {"Citation": "Doulaptsi M, Prokopakis E, Seys S, Pugin B, Steelant B, Hellings P. Visual analogue scale for sino-nasal symptom severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl Allergy. 2018;8:32.", "ArticleIdList": ["PMC6120084", "30186592"]}, {"Citation": "Verkerk MM, Bhatia D, Rimmer J, Earls P, Sacks S, Harvey RJ. Intranasal steroids and the myth of mucosal atrophy:a systematic review of original histological assessments. Am J Rhinol Allergy. 2015;29:3\u201318.", "ArticleIdList": ["25590306"]}, {"Citation": "Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630:a randomized, double-blind, placebo-controlled trial. Rhinology. 2009;47:51\u20138.", "ArticleIdList": ["19382496"]}, {"Citation": "Jund R, Mondigler M, Stammer H, Stierna P, Bachert C. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015;135:42\u201350.", "ArticleIdList": ["PMC4487568", "25496178"]}, {"Citation": "Paparoupa M, Gillissen A. Is Myrtol\u00ae standardized a new alternative toward antibiotics. Pharmacogn Rev. 2016;10:143\u20136.", "ArticleIdList": ["PMC5214559", "28082798"]}, {"Citation": "Ponikau JU, Hamilos DL, Barreto A, Cecil J, Jones SW, Manthei SE, et al. An exploratory trial of Cyclamen europaeum extract for acute rhinosinusitis. Laryngoscope. 2012;122:1887\u201392.", "ArticleIdList": ["22674586"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "28"}, {"Year": "2020", "Month": "12", "Day": "12"}, {"Year": "2021", "Month": "4", "Day": "29", "Hour": "6", "Minute": "34"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33912859", "PMC8054925", "10.4274/tao.2020.6098", "44492"]}}], "PubmedBookArticle": []}